InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627
$4.65 +4.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.65 +6.41% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−16.4Net income−9.3Fiscal year 2017Operating income−17.4Net income−25.3Fiscal year 2018Operating income−20.5Net income−14.4Fiscal year 2019Revenue3.0Operating income−4.2Net income−6.2Fiscal year 2020Revenue0.0 −100.0%Operating income−20.0Net income−24.6EPS, diluted−5.28Fiscal year 2021Revenue0.6Operating income−22.7Net income−56.7EPS, diluted−3.82Fiscal year 2022Revenue39.9 +6,665.7%Operating income18.2Net income17.9EPS, diluted0.87Fiscal year 2023Revenue19.0 −52.2%Operating income−10.6Net income−10.0 −155.8%EPS, diluted−0.46Fiscal year 2024Revenue11.0 −42.3%Operating income−62.1Net income−57.5EPS, diluted−2.15Fiscal year 2025Revenue14.2 +29.1%Operating income−38.6Net income−49.6EPS, diluted−0.80
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 3.0 0.0 0.6 39.9 19.0 11.0 14.2
Growth −100.0% +6,665.7% −52.2% −42.3% +29.1%
Operating income −16.4 −17.4 −20.5 −4.2 −20.0 −22.7 18.2 −10.6 −62.1 −38.6
Net income −9.3 −25.3 −14.4 −6.2 −24.6 −56.7 17.9 −10.0 −57.5 −49.6
Growth −155.8%
EPS, diluted n/a n/a n/a n/a −5.28 −3.82 0.87 −0.46 −2.15 −0.80

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Operating margin−139.8%Net margin−205.6%Free cash flow margin−120.6%Fiscal year 2020Fiscal year 2021Operating margin−3,854.8%Net margin−9,625.3%Fiscal year 2022Operating margin45.7%Net margin44.9%Fiscal year 2023Operating margin−55.5%Net margin−52.4%Fiscal year 2024Operating margin−564.7%Net margin−523.4%Fiscal year 2025Operating margin−271.9%Net margin−349.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −139.8% n/a −3,854.8% 45.7% −55.5% −564.7% −271.9%
Net margin n/a n/a n/a −205.6% n/a −9,625.3% 44.9% −52.4% −523.4% −349.3%
Free cash flow margin n/a n/a n/a −120.6% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−13.2Fiscal year 2017Operating cash flow−15.4Fiscal year 2018Operating cash flow−18.8Fiscal year 2019Operating cash flow−3.6Capital expenditure−0.0Free cash flow−3.6Fiscal year 2020Operating cash flow−6.8Capital expenditure0.0Free cash flow−6.8Fiscal year 2021Operating cash flow−19.4Fiscal year 2022Operating cash flow14.3Fiscal year 2023Operating cash flow−1.1Fiscal year 2024Operating cash flow−25.6Fiscal year 2025Operating cash flow−35.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.2 −15.4 −18.8 −3.6 −6.8 −19.4 14.3 −1.1 −25.6 −35.3
Capital expenditure n/a n/a n/a −0.0 0.0 n/a n/a n/a n/a n/a
Free cash flow n/a n/a n/a −3.6 −6.8 n/a n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash11.6Shareholders’ equity17.1Fiscal year 2017Cash8.9Shareholders’ equity16.8Fiscal year 2018Cash8.7Shareholders’ equity−1.7Fiscal year 2019Cash1.5Shareholders’ equity−7.6Fiscal year 2020Cash16.4Shareholders’ equity−13.5Fiscal year 2021Cash24.5Shareholders’ equity22.2Fiscal year 2022Cash42.6Shareholders’ equity46.2Fiscal year 2023Cash50.5Shareholders’ equity49.9Fiscal year 2024Cash30.3Total debt0.0Net cash (debt)30.3Shareholders’ equity6.7Debt to equity0.00Fiscal year 2025Cash45.1Total debt1.1Net cash (debt)44.0Shareholders’ equity15.3Debt to equity0.07
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 11.6 8.9 8.7 1.5 16.4 24.5 42.6 50.5 30.3 45.1
Total debt n/a n/a n/a n/a n/a n/a n/a n/a 0.0 1.1
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a n/a 30.3 44.0
Shareholders’ equity 17.1 16.8 −1.7 −7.6 −13.5 22.2 46.2 49.9 6.7 15.3
Debt to equity n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.07

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a −139.8% n/a −3,854.8% 45.7% −55.5% −564.7% −271.9%
n/a n/a n/a −205.6% n/a −9,625.3% 45.7% −52.4% −523.4% −349.3%
n/a n/a n/a −205.6% n/a −9,625.3% 44.9% −52.4% −523.4% −349.3%
n/a n/a n/a −120.6% n/a n/a n/a n/a n/a n/a
Spending
n/a n/a n/a 182.6% n/a n/a n/a n/a n/a n/a
n/a n/a n/a 60.7% n/a 1,378.8% 18.2% 62.8% 165.7% 154.9%
n/a n/a n/a 0.8% n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a 1.7% n/a n/a n/a
Returns
−54.6% −150.8% n/a n/a n/a −255.1% 38.7% −20.0% −855.6% −323.1%
−44.2% −89.4% −89.6% −345.8% −139.2% −217.4% 36.5% −18.5% −156.1% −98.7%
Balance and payout
n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.07
18.9% 40.7% 34.2% 523.8% 176.2% 14.8% 5.6% 7.5% 30.6% 69.5%